annual CAPEX:
$1.93M-$533.00K(-21.63%)Summary
- As of today (September 17, 2025), KROS annual capital expenditures is $1.93 million, with the most recent change of -$533.00 thousand (-21.63%) on December 31, 2024.
- During the last 3 years, KROS annual CAPEX has risen by +$907.00 thousand (+88.57%).
- KROS annual CAPEX is now -21.63% below its all-time high of $2.46 million, reached on December 31, 2023.
Performance
KROS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$720.00K+$155.00K(+27.43%)Summary
- As of today (September 17, 2025), KROS quarterly capital expenditures is $720.00 thousand, with the most recent change of +$155.00 thousand (+27.43%) on June 30, 2025.
- Over the past year, KROS quarterly CAPEX has increased by +$410.00 thousand (+132.26%).
- KROS quarterly CAPEX is now -32.20% below its all-time high of $1.06 million, reached on March 31, 2023.
Performance
KROS quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$1.96M+$410.00K(+26.45%)Summary
- As of today (September 17, 2025), KROS TTM capital expenditures is $1.96 million, with the most recent change of +$410.00 thousand (+26.45%) on June 30, 2025.
- Over the past year, KROS TTM CAPEX has dropped by -$387.00 thousand (-16.49%).
- KROS TTM CAPEX is now -20.45% below its all-time high of $2.46 million, reached on December 31, 2023.
Performance
KROS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
KROS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.6% | +132.3% | -16.5% |
| 3 y3 years | +88.6% | +27.0% | +92.5% |
| 5 y5 years | +612.5% | +2471.4% | +585.3% |
KROS CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.6% | +88.6% | -32.2% | +309.1% | -20.4% | +92.5% |
| 5 y | 5-year | -21.6% | +612.5% | -32.2% | +2471.4% | -20.4% | +737.6% |
| alltime | all time | -21.6% | +789.9% | -32.2% | >+9999.0% | -20.4% | >+9999.0% |
KROS CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $720.00K(+27.4%) | $1.96M(+26.5%) |
| Mar 2025 | - | $565.00K(+95.5%) | $1.55M(-19.7%) |
| Dec 2024 | $1.93M(-21.6%) | $289.00K(-25.1%) | $1.93M(-11.5%) |
| Sep 2024 | - | $386.00K(+24.5%) | $2.18M(-7.0%) |
| Jun 2024 | - | $310.00K(-67.2%) | $2.35M(-0.0%) |
| Mar 2024 | - | $946.00K(+74.9%) | $2.35M(-4.7%) |
| Dec 2023 | $2.46M(+98.5%) | $541.00K(-1.6%) | $2.46M(+8.4%) |
| Sep 2023 | - | $550.00K(+76.8%) | $2.27M(+19.7%) |
| Jun 2023 | - | $311.00K(-70.7%) | $1.90M(-11.9%) |
| Mar 2023 | - | $1.06M(+202.6%) | $2.16M(+73.7%) |
| Dec 2022 | $1.24M | $351.00K(+99.4%) | $1.24M(+18.3%) |
| Sep 2022 | - | $176.00K(-69.0%) | $1.05M(+3.0%) |
| Jun 2022 | - | $567.00K(+285.7%) | $1.02M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $147.00K(-7.5%) | $961.00K(-6.2%) |
| Dec 2021 | $1.02M(+248.3%) | $159.00K(+9.7%) | $1.02M(+10.7%) |
| Sep 2021 | - | $145.00K(-71.6%) | $925.00K(+14.2%) |
| Jun 2021 | - | $510.00K(+142.9%) | $810.00K(+147.0%) |
| Mar 2021 | - | $210.00K(+250.0%) | $328.00K(+11.6%) |
| Dec 2020 | $294.00K(+8.5%) | $60.00K(+100.0%) | $294.00K(+25.6%) |
| Sep 2020 | - | $30.00K(+7.1%) | $234.00K(-18.2%) |
| Jun 2020 | - | $28.00K(-84.1%) | $286.00K(-33.3%) |
| Mar 2020 | - | $176.00K(+114.6%) | $429.00K(+69.6%) |
| Dec 2019 | $271.00K(+24.9%) | - | - |
| Sep 2019 | - | $82.00K(-52.0%) | $253.00K(+48.0%) |
| Jun 2019 | - | $171.00K(>+9900.0%) | $171.00K(>+9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $217.00K | - | - |
FAQ
- What is Keros Therapeutics, Inc. annual capital expenditures?
- What is the all time high annual CAPEX for Keros Therapeutics, Inc.?
- What is Keros Therapeutics, Inc. annual CAPEX year-on-year change?
- What is Keros Therapeutics, Inc. quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Keros Therapeutics, Inc.?
- What is Keros Therapeutics, Inc. quarterly CAPEX year-on-year change?
- What is Keros Therapeutics, Inc. TTM capital expenditures?
- What is the all time high TTM CAPEX for Keros Therapeutics, Inc.?
- What is Keros Therapeutics, Inc. TTM CAPEX year-on-year change?
What is Keros Therapeutics, Inc. annual capital expenditures?
The current annual CAPEX of KROS is $1.93M
What is the all time high annual CAPEX for Keros Therapeutics, Inc.?
Keros Therapeutics, Inc. all-time high annual capital expenditures is $2.46M
What is Keros Therapeutics, Inc. annual CAPEX year-on-year change?
Over the past year, KROS annual capital expenditures has changed by -$533.00K (-21.63%)
What is Keros Therapeutics, Inc. quarterly capital expenditures?
The current quarterly CAPEX of KROS is $720.00K
What is the all time high quarterly CAPEX for Keros Therapeutics, Inc.?
Keros Therapeutics, Inc. all-time high quarterly capital expenditures is $1.06M
What is Keros Therapeutics, Inc. quarterly CAPEX year-on-year change?
Over the past year, KROS quarterly capital expenditures has changed by +$410.00K (+132.26%)
What is Keros Therapeutics, Inc. TTM capital expenditures?
The current TTM CAPEX of KROS is $1.96M
What is the all time high TTM CAPEX for Keros Therapeutics, Inc.?
Keros Therapeutics, Inc. all-time high TTM capital expenditures is $2.46M
What is Keros Therapeutics, Inc. TTM CAPEX year-on-year change?
Over the past year, KROS TTM capital expenditures has changed by -$387.00K (-16.49%)